Reversibly blocked plasmin, t-PA hybrid fibrinolytic enzymes and pharmaceutical compositions and anti-thrombotic use thereof
作者： Jeffery H. Robinson , Ian Dodd
DOI:
关键词:
摘要: A fibrinolytically active hybrid protein which comprises one chain of a 2-chain protease linked to different protease, or the same at least chains in being derived from such that has catalytic site essential for fibrinolytic activity is optionally blocked by removable blocking group.
lens.org 参考文章(9)
Richard Anthony Godwin Smith, Enzyme derivatives for use in the treatment of venous thrombosis, compositions containing them and their preparation ,(1979)
Masanao Shinohara, Wasei Miyazaki, Yasuo Nakayama, Urokinase-plasmin complex adsorbable by fibrin and process for preparing same ,(1984)
Kenneth C. Robbins, Louis Summaria, Plasminogen activator complex ,(1977)
Richard A. G. Smith, Novel enzyme derivatives ,(1984)
Richard A. G. Smith, Enzyme derivatives for use in the treatment of venous thrombosis ,(1980)
Narender Kumar Kalyan, Paul Porwen Hung, Shawguang Lin Lee, Poly-kringle plasminogen activator ,(1986)
Jeffery Hugh Robinson, Ian Dodd, Fibronolytically active hybrid protein, process for its preparation and pharmaceutical composition ,(1984)
Ian C O Smithkline Beecham Pharmaceuticals Dodd, Degraded species of tissue-type plasminogen activator, pharmaceutical composition and method of preparation ,(1986)
Richard A. G. Smith, Pharmacologically active compounds ,(1983)